ECU
EVH icon

Eisler Capital (US)’s Evolent Health EVH Stock Holding History

Eisler Capital (US)’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-41,066
Closed -$785K – 533
2024
Q2 		$785K Buy
+41,066
New +$1.05M 0.01% 525

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Eisler Capital (US)'s EVH Position: Q3 2024 in Review

Eisler Capital (US) sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 41,066 shares — an estimated $785K sold.

Eisler Capital (US) first reported a position in EVH in Q2 2024 and held it in 1 quarter. The position peaked at $785K in Q2 2024. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • Eisler Capital (US) reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 41,066 Evolent Health shares in Q3 2024, an estimated $785K.
  • Eisler Capital (US) first reported a position in Evolent Health in Q2 2024 and held it in 1 quarter.
  • Eisler Capital (US)'s Evolent Health position peaked at $785K in Q2 2024.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.